Zoetis unveils its vision for EuAfME
Zoetis, formerly the animal health business unit of Pfizer, announced its vision for business in Europe, Africa and the Middle East (EuAfME). Building on 60 years of experience in the animal health sector, the company aims to have its products, services and people as the most valued by animal health customers around the region, and the world.
“We are united around this shared vision, and we strive every day to help customers meet their real-world challenges through quality medicines and vaccines, complemented by diagnostic products, genetic tests and a range of services,” said Alejandro Bernal, Zoetis Executive Vice President and Area President for the EuAfME region. “As the largest standalone company in the industry, we are dedicated solely to animal health and focusing on our core business so our customers can grow theirs.”
Zoetis combines local presence with strong customer relationships across the EuAfME region, where Zoetis has 2,600 colleagues, offices in 17 countries, (speaking 20 different languages), conducting business in more than 60 countries. That presence is backed by strong manufacturing and Research and Development capabilities; Zoetis has four manufacturing sites in Europe: Catania (Italy), Louvain-la-Neuve (Belgium), Medolla (Italy), Olot (Spain) and three Research and Development sites: Louvain-la-Neuve, Olot and Zaventem (Belgium).
In addition to working closely with customers, Zoetis strives to collaborate with universities and other research organisations, to help advance the animal health sector and those who raise and care for animals.
[Missing text /esp/commentform/login for en]
[Missing text /esp/commentform/registertocomment for en]